Vimian Group AB (publ)

PINK:VIMGF USA Diagnostics & Research
Market Cap
$2.37 Billion
Market Cap Rank
#8082 Global
#4153 in USA
Share Price
$4.50
Change (1 day)
+0.00%
52-Week Range
$3.50 - $4.50
All Time High
$4.50
About

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic… Read more

Vimian Group AB (publ) (VIMGF) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of December 2025: 0.080x

Based on the latest financial reports, Vimian Group AB (publ) (VIMGF) has a cash flow conversion efficiency ratio of 0.080x as of December 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($56.60 Million) by net assets ($708.80 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Vimian Group AB (publ) - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Vimian Group AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Vimian Group AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vimian Group AB (publ) ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Vimian Group AB (publ) (2018–2025)

The table below shows the annual cash flow conversion efficiency of Vimian Group AB (publ) from 2018 to 2025.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $708.80 Million $105.70 Million 0.149x +81.34%
2024-12-31 $706.50 Million $58.10 Million 0.082x +251.58%
2023-12-31 $526.71 Million $-28.58 Million -0.054x -203.20%
2022-12-31 $481.50 Million $25.31 Million 0.053x +17.74%
2021-12-31 $358.64 Million $16.01 Million 0.045x +155.06%
2020-12-31 $274.25 Million $4.80 Million 0.018x -41.17%
2019-12-31 $52.02 Million $1.55 Million 0.030x +128.80%
2018-12-31 $19.59 Million $-2.02 Million -0.103x --